SS
APYX icon

Steve Schonfeld’s Apyx Medical APYX Stock Holding History

Steve Schonfeld’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,900
Closed -$172K – 1346
2020
Q2 		$172K Buy
+30,900
New +$128K ﹤0.01% 1131
2018
Q4 		– Sell
-100,000
Closed -$710K – 1047
2018
Q3 		$710K Buy
100,000
+50,000
+100% +$278K 0.03% 505
2018
Q2 		$218K Buy
+50,000
New +$184K 0.01% 691

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steve Schonfeld's APYX Position: Q3 2020 in Review

Steve Schonfeld sold out of Apyx Medical (APYX) in Q3 2020, closing a stake of 30,900 shares — an estimated $172K sold.

Steve Schonfeld first reported a position in APYX in Q2 2018 and held it in 3 quarters. The position peaked at $710K in Q3 2018. 61 funds tracked by Wall St. Rank hold APYX as of Q3 2020.

  • Steve Schonfeld reported no remaining Apyx Medical position as of Q3 2020 after selling out during the quarter.
  • Steve Schonfeld sold 30,900 Apyx Medical shares in Q3 2020, an estimated $172K.
  • Steve Schonfeld first reported a position in Apyx Medical in Q2 2018 and held it in 3 quarters.
  • Steve Schonfeld's Apyx Medical position peaked at $710K in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.